标题
An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
作者
关键词
-
出版物
Nucleus
Volume 9, Issue 1, Pages 246-257
出版商
Informa UK Limited
发表日期
2018-04-05
DOI
10.1080/19491034.2018.1460045
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metformin alleviates ageing cellular phenotypes in Hutchinson-Gilford progeria syndrome dermal fibroblasts
- (2017) Seul-Ki Park et al. EXPERIMENTAL DERMATOLOGY
- Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes
- (2017) Benjamin A. Hilton et al. FASEB JOURNAL
- Delivery technologies for genome editing
- (2017) Hao Yin et al. NATURE REVIEWS DRUG DISCOVERY
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- (2017) Diana Gabriel et al. Oncotarget
- A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells
- (2017) Leigh Atchison et al. Scientific Reports
- In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming
- (2016) Alejandro Ocampo et al. CELL
- Repression of the Antioxidant NRF2 Pathway in Premature Aging
- (2016) Nard Kubben et al. CELL
- Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeClinical Perspective
- (2016) Leslie B. Gordon et al. CIRCULATION
- Interruption of progerin–lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype
- (2016) Su-Jin Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of LMNA splicing as a strategy to treat prelamin A diseases
- (2016) John M. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds
- (2016) Nard Kubben et al. METHODS
- In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
- (2016) Keiichiro Suzuki et al. NATURE
- Anti-Aging Strategies Based on Cellular Reprogramming
- (2016) Alejandro Ocampo et al. TRENDS IN MOLECULAR MEDICINE
- Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation
- (2016) S Blondel et al. Cell Death & Disease
- Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes
- (2016) Ray Kreienkamp et al. Oncotarget
- Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice
- (2016) Chen-Yu Liao et al. Cell Reports
- Antisense-Based Progerin Downregulation in HGPS-Like Patients’ Cells
- (2016) Karim Harhouri et al. Cells
- Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria
- (2015) Zheng-Mei Xiong et al. AGING CELL
- Truncated prelamin A expression in HGPS-like patients: a transcriptional study
- (2015) Florian Barthélémy et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Transgene silencing of the Hutchinson-Gilford progeria syndrome mutation results in a reversible bone phenotype, whereas resveratrol treatment does not show overall beneficial effects
- (2015) Charlotte Strandgren et al. FASEB JOURNAL
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- NF-κB activation impairs somatic cell reprogramming in ageing
- (2015) Clara Soria-Valles et al. NATURE CELL BIOLOGY
- All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype
- (2015) Camilla Pellegrini et al. Oncotarget
- Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts
- (2014) Diana Gabriel et al. AGING CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome
- (2014) Leslie B. Gordon et al. CIRCULATION
- Erratum - Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria
- (2014) V. Cenni et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Proteasome inhibitor MG132 modulates inflammatory pain by central mechanisms in adjuvant arthritis
- (2014) Aisha Siddiqah Ahmed et al. International Journal of Rheumatic Diseases
- CRISPR-Cas systems for editing, regulating and targeting genomes
- (2014) Jeffry D Sander et al. NATURE BIOTECHNOLOGY
- Engineering adeno-associated viruses for clinical gene therapy
- (2014) Melissa A. Kotterman et al. NATURE REVIEWS GENETICS
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Chemical Inhibition of NAT10 Corrects Defects of Laminopathic Cells
- (2014) D. Larrieu et al. SCIENCE
- Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective
- (2014) Pierre Cau et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Hutchinson-Gilford progeria syndrome through the lens of transcription
- (2013) Miron Prokocimer et al. AGING CELL
- Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment
- (2013) Ricardo Villa-Bellosta et al. CIRCULATION
- Identification of mitochondrial dysfunction in Hutchinson–Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture
- (2013) José Rivera-Torres et al. Journal of Proteomics
- Preventive and Therapeutic Effects of MG132 by Activating Nrf2-ARE Signaling Pathway on Oxidative Stress-Induced Cardiovascular and Renal Injury
- (2013) Wenpeng Cui et al. Oxidative Medicine and Cellular Longevity
- Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice
- (2013) Xiao Miao et al. Oxidative Medicine and Cellular Longevity
- Targeting Isoprenylcysteine Methylation Ameliorates Disease in a Mouse Model of Progeria
- (2013) M. X. Ibrahim et al. SCIENCE
- Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB
- (2012) Yuehui Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome
- (2012) John J. Graziotto et al. Autophagy
- Resveratrol Rescues SIRT1-Dependent Adult Stem Cell Decline and Alleviates Progeroid Features in Laminopathy-Based Progeria
- (2012) Baohua Liu et al. Cell Metabolism
- Mapping of lamin A- and progerin-interacting genome regions
- (2012) Nard Kubben et al. CHROMOSOMA
- Nuclear lamina defects cause ATM-dependent NF- B activation and link accelerated aging to a systemic inflammatory response
- (2012) F. G. Osorio et al. GENES & DEVELOPMENT
- Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome
- (2012) R. P. McCord et al. GENOME RESEARCH
- Expression of the Hutchinson-Gilford Progeria Mutation during Osteoblast Development Results in Loss of Osteocytes, Irregular Mineralization, and Poor Biomechanical Properties
- (2012) Eva Schmidt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nicotinic Acetylcholine Receptor Agonists Attenuate Septic Acute Kidney Injury in Mice by Suppressing Inflammation and Proteasome Activity
- (2012) Prodyot K. Chatterjee et al. PLoS One
- Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome
- (2012) L. B. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct perturbation of the translatome by the antidiabetic drug metformin
- (2012) O. Larsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapamycin Reverses Elevated mTORC1 Signaling in Lamin A/C-Deficient Mice, Rescues Cardiac and Skeletal Muscle Function, and Extends Survival
- (2012) F. J. Ramos et al. Science Translational Medicine
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine
- (2011) Shane A. Richards et al. HUMAN MOLECULAR GENETICS
- A conserved splicing mechanism of the LMNA gene controls premature aging
- (2011) Isabel C. Lopez-Mejia et al. HUMAN MOLECULAR GENETICS
- Recapitulation of premature ageing with iPSCs from Hutchinson–Gilford progeria syndrome
- (2011) Guang-Hui Liu et al. NATURE
- Splicing-Directed Therapy in a New Mouse Model of Human Accelerated Aging
- (2011) F. G. Osorio et al. Science Translational Medicine
- Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells
- (2011) K. Cao et al. Science Translational Medicine
- Cardiovascular Pathology in Hutchinson-Gilford Progeria: Correlation With the Vascular Pathology of Aging
- (2010) Michelle Olive et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A Human iPSC Model of Hutchinson Gilford Progeria Reveals Vascular Smooth Muscle and Mesenchymal Stem Cell Defects
- (2010) Jinqiu Zhang et al. Cell Stem Cell
- Functional Coupling between the Extracellular Matrix and Nuclear Lamina by Wnt Signaling in Progeria
- (2010) Lidia Hernandez et al. DEVELOPMENTAL CELL
- An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria
- (2010) B. S. J. Davies et al. HUMAN MOLECULAR GENETICS
- Preventive Effect of a Proteasome Inhibitor on the Formation of Accelerated Atherosclerosis in Rabbits With Uremia
- (2010) Bing Feng et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Vitamin D, disease and therapeutic opportunities
- (2010) Lori A. Plum et al. NATURE REVIEWS DRUG DISCOVERY
- Progeria syndromes and ageing: what is the connection?
- (2010) Christopher R. Burtner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2
- (2009) Henryk Dreger et al. CARDIOVASCULAR RESEARCH
- Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients
- (2009) Gabriela Viteri et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
- (2008) Roger Bouillon et al. ENDOCRINE REVIEWS
- MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-κB and activator protein-1
- (2008) Pablo C. Ortiz-Lazareno et al. IMMUNOLOGY
- Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated
- (2008) Shao H. Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing
- (2008) Paola Scaffidi et al. NATURE CELL BIOLOGY
- Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
- (2008) Ignacio Varela et al. NATURE MEDICINE
- Phenotype and Course of Hutchinson–Gilford Progeria Syndrome
- (2008) Melissa A. Merideth et al. NEW ENGLAND JOURNAL OF MEDICINE
- A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model
- (2008) B. C. Capell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A
- (2007) Yiyong Liu et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started